WELCOME > Company > HISTORY

HISTORY

BUSINESS HISTORY

2011-NOW

  • 2017

    09
    New Research Building Completed

  • 2016

    05
    Partnership with ThermoFisher Scientific for real-time PCR

  • 2013

    11
    Awarded ‘Korea Technology Award (silver prize)’ and selected as ‘Korea Top 10 New Technologies 2013’
    01
    Food and Drug Administration Approval (KFDA) : PNAClamp™ EGFR, KRAS, BRAF

  • 2012

    06
    CE marking [(PNAClamp™ Mutation Detection Kit, PANA qPCR™ TB/NTM Detection Kit)]

  • 2011

    09
    Concluded a supply contract with Abnova (supplies diagnostic products for research worldwide)
    09
    Concluded a co-partner agreement with Merck Serono

  • 2010

    10
    Received Technology Innovation Award from Frost & Sullivan, worldwide global market research and con
    03
    Obtained ISO 13485:2003 certification(PANArray™ HPV Genotyping Chip)
    03
    Obtained ISO 9001:2008 certification
    01
    Acquisition of a non-exclusive license on micro array for human in-vitro diagnostics from ABI

  • 2009

    12
    Succeeded in the commercialization of world's first PNA Chip
    12
    Acquired a license for pharmaceutical manufacturing by KFDA : PANArray™ HPV Chip
    08
    Expansive rechartering of exclusive franchise agreement of PNA

  • 2008

    10
    M&A between Panagene Inc. and Koram Panagene Ltd. (listed in KOSDAQ)
    02
    Distributorship agreement with Eurogentec, Belgium
    02
    Movement of headquarters to a new building at current address

  • 2007

    06
    Acquired a non-exclusive license on PNA monomers
    06
    Concluded an exclusive supply contract with AdvanDx in U.S. (designed for diagnostic products in hos

  • 2006

    12
    Distributorship agreement with CBC, Japan
    07
    Secured the core technology of PNA mass production and acquired of worldwide exclusive supply right

  • 2005

    05
    PNA supply agreement for commercial diagnostic kit with DAKO, Denmark
    03
    Concluded a PNA mass production contract with PPL

  • 2004

    06
    Concluded a PNA supply contract with ISIS Pharmaceutical
    04
    Awarded at TIDES 2004 for best thesis

  • 2003

    03
    Nomination as a cluster R&D entrepreneur with the unique technology

  • 2002

    02
    Patent filed on PNA Bts monomer and chemical process for unique synthesis of PNA oligomers

  • 2001

    04
    Foundation of PANAGENE Inc.